TY - JOUR
T1 - Identification of an endocannabinoid gut-brain vagal mechanism controlling food reward and energy homeostasis
AU - Berland, Chloé
AU - Castel, Julien
AU - Terrasi, Romano
AU - Montalban, Enrica
AU - Foppen, Ewout
AU - Martin, Claire
AU - Muccioli, Giulio G.
AU - Luquet, Serge
AU - Gangarossa, Giuseppe
N1 - Funding Information:
We thank Chloé Morel, Rim Hassouna, Anne-Sophie Delbes, Daniela Herrera Moro and Raphaël Denis for technical advice and support; Adrien Paquot (BPBL/UCLouvain) for his help with eCB quantification; Olja Kacanski for administrative support; Isabelle Le Parco, Ludovic Maingault, Angélique Dauvin, Aurélie Djemat, Florianne Michel, Magguy Boa and Daniel Quintas for animals’ care. We acknowledge the technical platform Functional and Physiological Exploration platform (FPE) of the Université de Paris (BFA-UMR 8251) and the animal facility Buffon of the Institut Jacques Monod. This work was supported by the Fyssen Foundation, Nutricia Research Foundation, Allen Foundation Inc., Agence Nationale de la Recherche (ANR-21-CE14-0021-01), Fédération pour la Recherche sur le Cerveau and Association France Parkinson, Université de Paris and CNRS. CB and EM were supported by fellowships from the Fondation pour la Recherche Médicale (FRM). Telemetry experiments were supported by the Continuous Glucose Telemetry Award 2018 (Dr. Denis) and sponsored by Data Sciences International.
Funding Information:
We thank Chloé Morel, Rim Hassouna, Anne-Sophie Delbes, Daniela Herrera Moro and Raphaël Denis for technical advice and support; Adrien Paquot (BPBL/UCLouvain) for his help with eCB quantification; Olja Kacanski for administrative support; Isabelle Le Parco, Ludovic Maingault, Angélique Dauvin, Aurélie Djemat, Florianne Michel, Magguy Boa and Daniel Quintas for animals’ care. We acknowledge the technical platform Functional and Physiological Exploration platform (FPE) of the Université de Paris (BFA-UMR 8251) and the animal facility Buffon of the Institut Jacques Monod. This work was supported by the Fyssen Foundation, Nutricia Research Foundation, Allen Foundation Inc., Agence Nationale de la Recherche (ANR-21-CE14-0021-01), Fédération pour la Recherche sur le Cerveau and Association France Parkinson , Université de Paris and CNRS. CB and EM were supported by fellowships from the Fondation pour la Recherche Médicale (FRM). Telemetry experiments were supported by the Continuous Glucose Telemetry Award 2018 (Dr. Denis) and sponsored by Data Sciences International.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/4
Y1 - 2022/4
N2 - The regulation of food intake, a sine qua non requirement for survival, thoroughly shapes feeding and energy balance by integrating both homeostatic and hedonic values of food. Unfortunately, the widespread access to palatable food has led to the development of feeding habits that are independent from metabolic needs. Among these, binge eating (BE) is characterized by uncontrolled voracious eating. While reward deficit seems to be a major contributor of BE, the physiological and molecular underpinnings of BE establishment remain elusive. Here, we combined a physiologically relevant BE mouse model with multiscale in vivo approaches to explore the functional connection between the gut-brain axis and the reward and homeostatic brain structures. Our results show that BE elicits compensatory adaptations requiring the gut-to-brain axis which, through the vagus nerve, relies on the permissive actions of peripheral endocannabinoids (eCBs) signaling. Selective inhibition of peripheral CB1 receptors resulted in a vagus-dependent increased hypothalamic activity, modified metabolic efficiency, and dampened activity of mesolimbic dopamine circuit, altogether leading to the suppression of palatable eating. We provide compelling evidence for a yet unappreciated physiological integrative mechanism by which variations of peripheral eCBs control the activity of the vagus nerve, thereby in turn gating the additive responses of both homeostatic and hedonic brain circuits which govern homeostatic and reward-driven feeding. In conclusion, we reveal that vagus-mediated eCBs/CB1R functions represent an interesting and innovative target to modulate energy balance and counteract food-reward disorders.
AB - The regulation of food intake, a sine qua non requirement for survival, thoroughly shapes feeding and energy balance by integrating both homeostatic and hedonic values of food. Unfortunately, the widespread access to palatable food has led to the development of feeding habits that are independent from metabolic needs. Among these, binge eating (BE) is characterized by uncontrolled voracious eating. While reward deficit seems to be a major contributor of BE, the physiological and molecular underpinnings of BE establishment remain elusive. Here, we combined a physiologically relevant BE mouse model with multiscale in vivo approaches to explore the functional connection between the gut-brain axis and the reward and homeostatic brain structures. Our results show that BE elicits compensatory adaptations requiring the gut-to-brain axis which, through the vagus nerve, relies on the permissive actions of peripheral endocannabinoids (eCBs) signaling. Selective inhibition of peripheral CB1 receptors resulted in a vagus-dependent increased hypothalamic activity, modified metabolic efficiency, and dampened activity of mesolimbic dopamine circuit, altogether leading to the suppression of palatable eating. We provide compelling evidence for a yet unappreciated physiological integrative mechanism by which variations of peripheral eCBs control the activity of the vagus nerve, thereby in turn gating the additive responses of both homeostatic and hedonic brain circuits which govern homeostatic and reward-driven feeding. In conclusion, we reveal that vagus-mediated eCBs/CB1R functions represent an interesting and innovative target to modulate energy balance and counteract food-reward disorders.
UR - https://www.scopus.com/pages/publications/85123493330
U2 - 10.1038/s41380-021-01428-z
DO - 10.1038/s41380-021-01428-z
M3 - Article
C2 - 35075269
SN - 1359-4184
VL - 27
SP - 2340
EP - 2354
JO - Molecular psychiatry
JF - Molecular psychiatry
IS - 4
ER -